Skip to main content
Joanne Mortimer, MD, Oncology, Duarte, CA, City of Hope Comprehensive Cancer Center

JoanneMortimerMD

Oncology Duarte, CA

Breast Cancer, Hematologic Oncology

Vice Chair and Professor, Department of Medical Oncology & Therapeutics Research; Director, Women's Cancer Programs, Co-director, Breast Cancer Program at City of Hope

Dr. Mortimer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Mortimer's full profile

Already have an account?

  • Office

    Medical Oncology and Therapeutics Research
    1500 East Duarte Road
    Duarte, CA 91010
    Phone+1 626-256-4673
    Fax+1 626-218-8233
  • Is this information wrong?

Summary

  • I am a board certified medical oncologist with specialization in breast and women's cancers. I have been part of City of Hope team since 2007 and am currently the vice chair and professor of the Department of Medical Oncology and Therapeutic Research and co-director of the Breast Cancer Program.

    I love working with women; they’re amazing people. They get a diagnosis that is, at times, potentially fatal, and manage to get through it while still taking care of their families and kids, coming out the other side as stronger people.

Education & Training

  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1980 - 1982
  • Cleveland Clinic Foundation
    Cleveland Clinic FoundationResidency, Internal Medicine, 1977 - 1980
  • Loyola University Chicago Stritch School of Medicine
    Loyola University Chicago Stritch School of MedicineClass of 1977

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2004 - 2026
  • VA State Medical License
    VA State Medical License 2002 - 2006
  • OH State Medical License
    OH State Medical License 1979 - 1982
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • ERα-Mediated Cell Cycle Progression Is an Important Requisite for CDK4/6 Inhibitor Response in HR+ Breast Cancer  
    Joanne Mortimer, Laura Kruper, Raju Pillai, George Somlo, Yuan Yuan, Oncotarget

Press Mentions

  • Why Black Women Are More Likely to Die from Breast Cancer
    Why Black Women Are More Likely to Die from Breast CancerJune 10th, 2021
  • Sanofi’s, AstraZeneca’s and Radius’ Oral SERDs Could Establish Clinical Worth in ER+ Breast Cancer by Showing Similar Efficacy to Faslodex, Experts Say
    Sanofi’s, AstraZeneca’s and Radius’ Oral SERDs Could Establish Clinical Worth in ER+ Breast Cancer by Showing Similar Efficacy to Faslodex, Experts SayApril 6th, 2021
  • High Recurrence Score Linked with Chemotherapy Success in Breast Cancer
    High Recurrence Score Linked with Chemotherapy Success in Breast CancerOctober 8th, 2019
  • Join now to see all

Professional Memberships

Hospital Affiliations